UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of ~~December~~March ~~2025~~2026

Commission File Number: 001-42373

Gelteq Limited

(Registrant’s Name)

Level 19

644 Chapel Street

South Yarra VIC, 3141
Australia

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

INFORMATION CONTAINED IN THIS FORM 6-K REPORT

On ~~December~~March 918, ~~2025~~2026, Gelteq Limited (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) ~~will~~notifying bethe ~~providing~~Company ~~a virtual~~that ~~presentation~~the ~~hosted~~closing bybid ~~Investor~~price ~~Summit to~~per ~~certain~~share ~~private~~for ~~investors~~its ordinary shares, no par value, (“Ordinary Shares”) was below $1.00 Afor ~~copy~~a period of ~~this~~30 ~~presentation~~consecutive business days and that the Company did not meet the minimum bid price requirement set forth isin ~~furnished~~Nasdaq asListing ~~Exhibit~~Rule 995550(a)(2).1 The Nasdaq notification letter does not result in the immediate delisting of the Company’s Ordinary Shares, and the shares will continue to ~~this~~trade ~~Current~~uninterrupted ~~Report~~under onthe ~~Form 6-K~~symbol “GELS. ”

~~The~~Pursuant ~~foregoing~~to ~~(including~~Nasdaq ~~Exhibit~~Listing Rule ~~99.1~~5810(c)(3)(A), ~~will~~the ~~not be~~Company ~~deemed~~has toa becompliance ~~filed~~period ~~for purposes~~ of ~~Section~~one 18hundred ofeighty ~~the~~(180) ~~Securities~~calendar ~~and Exchange~~days, ~~Act~~or ofuntil ~~1934~~September 14, as2026 ~~amended~~ (the “~~Exchange Act~~Compliance Period”), or ~~otherwise~~to beregain ~~subject~~compliance towith Nasdaq’s minimum bid price requirement. If at any time during the ~~liabilities~~Compliance Period, the closing bid price per share of ~~that~~the ~~section,~~Company’s ~~nor~~Ordinary ~~will~~Shares itis beat ~~deemed~~least to$1.00 befor ~~incorporated~~a byminimum ~~reference~~of inten ~~any~~(10) ~~filing~~consecutive ~~under~~business days, Nasdaq will provide the ~~Securities~~ ~~Act~~Company ofa ~~1933,~~written asconfirmation ~~amended,~~of orcompliance and the ~~Exchange~~ ~~Act~~matter will be closed.

~~CAUTIONARY~~In ~~STATEMENT~~the ~~REGARDING~~event ~~FORWARD-LOOKING~~the Company does ~~STATEMENTS~~not regain compliance by September 14, 2026, the Company may be eligible for an additional 180 calendar day grace period. To qualify, the Company will be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the bid price requirement, and will need to provide written notice of its intention to cure the deficiency during the second compliance period, including by effecting a reverse stock split, if necessary.

This report on Form 6-K and the exhibits hereto contain “forward-looking statements” for purposes of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 that represent the Company’s beliefs, projections and predictions about future events. All statements other than statements of historical fact are “forward-looking statements,” including any projections of earnings, revenue or other financial items, any statements of the plans, strategies and objectives of management for future operations, any statements concerning proposed new projects or other developments, any statements regarding future economic conditions or performance, any statements of management’s beliefs, goals, strategies, intentions and objectives, and any statements of assumptions underlying any of the foregoing. Words such as “may”, “will”, “should”, “could”, “would”, “predicts”, “potential”, “continue”, “expects”, “anticipates”, “future”, “intends”, “plans”, “believes”, “estimates” and similar expressions, as well as statements in the future tense, identify forward-looking statements.

These statements are necessarily subjective and involve known and unknown risks, uncertainties and other important factors that could cause the Company’s actual results, performance or achievements, or industry results, to differ materially from any future results, performance or achievements described in or implied by such statements. Actual results may differ materially from expected results described in the Company’s forward-looking statements, including with respect to correct measurement and identification of factors affecting the Company’s business or the extent of their likely impact, and the accuracy and completeness of the publicly available information with respect to the factors upon which the Company’s business strategy is based or the success of the Company’s business.

Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of whether, or the times by which, the Company’s performance or results may be achieved. Forward-looking statements are based on information available at the time those statements are made and management’s belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. For a discussion of these risks and uncertainties, refer to Gelteq’s filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 20-F filed on November 17, 2025. Gelteq undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

Financial Statements and Exhibits.

The following exhibits are being filed herewith:

Exhibit Number		Description
99.1		Investor Presentation, dated December 9, 2025

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Gelteq Limited

	By:	/s/ Nathan Givoni
	Name:	Nathan Givoni
	Title:	Chief Executive Officer

Date: ~~December~~March 924, ~~2025~~2026

Filing Compare · Gelteq Ltd